Compare · head to head
CSPC Pharmaceutical vs Hansoh Pharmaceutical
CSPC Pharmaceutical ranks higher overall — 360 rank 79 vs 66.
CSPC Pharmaceutical leads on Value (67 vs 37), Growth (58 vs 50) and Sentiment (62 vs 50). Hansoh Pharmaceutical leads on Quality (59 vs 43).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | China | Hong Kong SAR China |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | X-Large | Large |
| ISIN | HK1093012172 | KYG549581067 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 79 | 66 |
| Value | 67 | 37 |
| Quality | 43 | 59 |
| Growth | 58 | 50 |
| Safety | NR | 69 |
| Sentiment | 62 | 50 |
| Quality details | ||
| Profitability | 35 | 71 |
| Cash Truth | NR | 48 |
CSPC Pharmaceutical vs Dong-A STCSPC Pharmaceutical vs Formosa LaboratoriesCSPC Pharmaceutical vs J. B. Chemicals & PharmaceuticalsCSPC Pharmaceutical vs Ildong HoldingsAdd a third stock →
Full analyses: CSPC Pharmaceutical · Hansoh Pharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100